3644 results for «2704»
3644 results
Typical chest pain: atypical angiogram
20 May 2026 – From EuroPCR 2026
This session addresses the management challenges posed by acute coronary syndromes when angiographic findings are ambiguous or atypical. It highlights the role of intravascular imaging in clarifying diagnoses and discusses recent insights from clinical cases and key studies such as DISCO and the latest NSTEMI EuroIntervention...
New tools for risk stratification in STEMI
20 May 2026 – From EuroPCR 2026
This session highlights novel tools and scores for risk stratification in ST-elevation myocardial infarction (STEMI) patients. It covers prognostic indices such as the index of microcirculatory resistance, the PREDICT-STEMI score, thrombus characteristics, sex differences in outcomes, renal impairment impacts, and benefits of complete revascularization strategies.
TAVI complications: the nurses and allied professionals' perspective
20 May 2026 – From EuroPCR 2026
This session highlights the critical role nurses and allied professionals (NAPs) play during TAVI complications. Through detailed clinical cases, it emphasizes their contributions in managing adverse events and explores the significance of structured debriefing to enhance team performance and patient outcomes.
Complications in coronary interventions
20 May 2026 – From EuroPCR 2026
This session reviews uncommon and challenging complications encountered during coronary interventions. Cases include brachial arteriovenous fistula following radial access, retained guidewires, coronary sinus perforation during device implantation, and complex atherectomy procedures, emphasizing preparedness and management strategies.
TAVI procedural complications - Part 6: paravalvular leak, basilica and more
20 May 2026 – From EuroPCR 2026
Delve into complex TAVI procedural complications including paravalvular leak and challenges such as BASILICA technique failures, aortic dissection, valve infolding, and valve dislocation. This session presents real-world cases illustrating troubleshooting strategies and innovative interventions like TAVI-in-TAVI procedures to address these critical scenarios.
Reliability and application of angio-based physiology in daily work
20 May 2026 – From EuroPCR 2026
This session evaluates the reliability and clinical application of angiography-based physiological assessments in daily practice. Topics include comparisons of angiography-derived microvascular resistance and flow metrics with invasive methods, reproducibility of quantitative flow ratio (QFR), and its correlation with symptom burden and other imaging modalities.
Angiography-based physiology: time to change your routine clinical practice?
20 May 2026 – From EuroPCR 2026
This session offers a critical appraisal of angiography-based physiology, with a focus on virtual fractional flow reserve (vFFR) technology. It reviews the latest clinical evidence, including insights from the FAST study programme and the FAST III randomised controlled trial. Gain a clear understanding of current guideline...
Managing life-threatening TAVI complications
19 May 2026 – From EuroPCR 2026
Manage life-threatening complications in TAVI procedures with a structured algorithm for identification and resolution. This session shares expert tips for handling specific severe complications and reviews best practices aimed at complication avoidance to enhance patient safety and procedural success.
Where to leave less behind: non-invasive CT and angiography-derived physiology for DCB lesion selection
20 May 2026 – From EuroPCR 2026
This session elucidates the role of non-invasive coronary CT and angiography-derived physiology in guiding lesion selection for drug-eluting balloon PCI. It emphasises integrating anatomical and physiological data to refine lesion preparation, strategy, and validation beyond angiography, and identifies scenarios where DEB PCI may not be optimal,...
All we need to know about vulnerable plaque
19 May 2026 – From EuroPCR 2026
Understand the critical importance of vulnerable plaque identification and management. This session covers optimal strategies for detecting vulnerable plaques, their prognostic implications, and evidence-based treatment approaches illustrated through detailed case presentations.
Reshaping what's possible in complex PCI with advanced sirolimus technology
21 May 2026 – From EuroPCR 2026
Focused on advancing complex PCI, this session explores strategies to minimise metal use through advanced sirolimus technologies and drug-coated balloon (DCB) therapies. It highlights the biological and pharmacokinetic characteristics of DCBs, key device design considerations, and practical approaches to less-metal PCI. Clinical cases illustrate challenges such...
From 3D coronary imaging to calcium modification: the future of PCI starts now
21 May 2026 – From EuroPCR 2026
The integration of advanced imaging and calcium modification techniques is reshaping percutaneous coronary intervention (PCI), offering new ways to plan and optimise complex procedures.
This EuroPCR 2026 session explores how 3D coronary imaging extends beyond conventional angiography to improve procedural planning and decision-making. It highlights the role...
Contemporary workflow for class IA PCI
19 May 2026 – From EuroPCR 2026
This EuroPCR 2026 session presents a contemporary workflow for Class IA PCI, focusing on how coronary physiology can be used to better understand disease patterns and guide procedural strategy in complex interventions.
It explores the role of physiological assessment in refining decision-making, alongside new co- and tri-registration...
Beyond the horizon - A prelude into TAVI and complex PCI solutions
19 May 2026 – From EuroPCR 2026
This session provides a comprehensive preview of evolving technologies and strategies shaping interventional cardiology. Discover the Myval Octapro+ transcatheter heart valve (THV) and its innovative design and procedural benefits demonstrated through a recorded case. Stay updated on Landmark and Compare TAVI trial data, and discover the...
TAVI procedural complications - Part 1: VSD, valve embolisation, and more
19 May 2026 – From EuroPCR 2026
This session focuses on the complex complications that can arise during TAVI procedures, such as ventricular septal defects, valve embolisation, and other critical events. Through detailed case analyses, it offers strategies for recognition, prevention, and management to improve patient safety and outcomes.
How to prevent and manage complex and complicated LAA closure cases?
19 May 2026 – From EuroPCR 2026
Designed to enhance procedural success in transcatheter left atrial appendage closure, this session addresses identification of complex anatomies, management of intraprocedural challenges, and strategies to prevent and handle complications, illustrated by practical case examples and expert evaluations.
How should I treat a patient with a calcified mitral anatomy?
19 May 2026 – From EuroPCR 2026
This session explores the management of patients with calcified mitral anatomy, from advanced imaging assessment to intervention planning. It evaluates the suitability of mitral annular calcification for transcatheter edge-to-edge repair (TEER) and discusses alternative therapeutic options for patients ineligible for TEER.
Value of imaging for treatment of calcified lesions
19 May 2026 – From EuroPCR 2026
This session highlights the critical value of imaging in the treatment of calcified coronary lesions. It reviews techniques for lesion modification, including innovative balloon-based strategies and multimodality approaches for balloon-uncrossable calcified left main bifurcations. The session also discusses the tactical cracking of calcified plaques and strategies...
Best clinical CTO cases
19 May 2026 – From EuroPCR 2026
This session presents exemplary clinical cases in chronic total occlusion (CTO) PCI, illustrating advanced procedural strategies and complication management. Cases include retrograde CTO-PCI complicated by catheter-induced dissection, expansion of antegrade CTO PCI limits with hybrid approaches, successful combined antegrade and retrograde hydrodynamic contrast recanalisation, and staged...
Evidence for new devices in management of coronary artery disease
19 May 2026 – From EuroPCR 2026
This session reviews the latest evidence on new devices in coronary artery disease management. It covers outcomes from randomized controlled trials including imaging- and physiology-guided PCI with the Bioadaptor device, long-term results of thinner-strut bioresorbable scaffolds, site-specific antithrombotic therapy evaluated in the DESyne BDS Plus Trial,...
